These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26752032)

  • 1. [ASC-US Pap Smear follow-up in a French department in 2077].
    Giuria C; Guiheneuc E; Coimet F; Caillez E; Baron C
    Sante Publique; 2015; 27(5):659-67. PubMed ID: 26752032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the first test of ASC-US smears by general practitioners of the Maine-et-Loire in 2014.].
    Theurier L; Tessier Cazeneuve C; Le Duc-Banaszuk AS; Baron C; de Casabianca C
    Sante Publique; 2018; 30(4):499-505. PubMed ID: 30540139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colposcopy Requirement of Papanicolaou Smear after Atypical Squamous Cells of Undetermined Significance (ASC-US) by Follow-up Protocol in an Urban Gynaecology Clinic, a Retrospective Study in Thailand.
    Perksanusak T; Sananpanichkul P; Chirdchim W; Bhamarapravatana K; Suwannarurk K
    Asian Pac J Cancer Prev; 2015; 16(12):4977-80. PubMed ID: 26163625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provider management of equivocal cervical cancer screening results among underserved women, 2009-2011: follow-up of atypical squamous cells of undetermined significance.
    Watson M; Benard V; Lin L; Rockwell T; Royalty J
    Cancer Causes Control; 2015 May; 26(5):759-64. PubMed ID: 25794897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Cytomorphological Features of ASC-H Cells Based on Histopathological Results Obtained from a Colposcopic Target Biopsy Immediately after Pap smear Sampling.
    Hata H; Okayama K; Iijima J; Teruya K; Shiina N; Caniz T; Ishii Y; Fujii M; Oda M; Okodo M
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2139-2143. PubMed ID: 31350977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of HPV-DNA in Pap smears containing ASC and AGC performed within Population Programme of Prophylaxis and Early Detection of Early Cervical Cancer.
    Ludwin A; Ludwin I; Pityński K; Jach R; Banaś T; Stangel-Wojcikiewicz K; Horbaczewska A; Pietrus M
    Przegl Lek; 2012; 69(11):1189-93. PubMed ID: 23646445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
    Sirovich BE; Gottlieb DJ; Fisher ES
    J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for cancer of the cervix with simultaneous pap smear and colposcopy. The efficacy of pap smear and colposcopy.
    Kuramoto H; Sugimoto N; Iida M
    Eur J Gynaecol Oncol; 2011; 32(1):73-6. PubMed ID: 21446330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of 114 abnormal Pap smear follow-up in ambulatory care.].
    Peccatte É; Vallée J; Trombert B; Savall A
    Sante Publique; 2018; 30(4):527-532. PubMed ID: 30540142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance.
    Kim H; Kim KY; Kim D; Hwang JH
    J Gynecol Oncol; 2024 May; 35(3):e26. PubMed ID: 38130135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
    Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing human papillomavirus of the female lower genital tract: failure of the Pap smear as a sole screening test.
    Lonky NM; Mahoney A; Sauer MV
    J Gynecol Surg; 1991; 7(3):183-9. PubMed ID: 10150073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
    Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
    J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests.
    Tavasoli SM; Kane E; Kupets R
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1461-1469. PubMed ID: 31053566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with the achievement of cervical smears by general practitioners.
    Rochoy M; Raginel T; Favre J; Soueres E; Messaadi N; Deken V; Duhamel A; Berkhout C
    BMC Res Notes; 2017 Dec; 10(1):723. PubMed ID: 29221494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.